US 9539231
Method for treating triple-negative breast cancer using AMPI-109
granted A61KA61K31/215A61K31/337
Quick answer
US patent 9539231 (Method for treating triple-negative breast cancer using AMPI-109) held by The Regents of the University of Colorado, a Body Corporate expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Jan 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/215, A61K31/337, A61K31/704